The U.S. Food and Drug Administration is scoffing at a "Doe" lawsuit filed by a company attorney trying to prevent being identified in an agency inspection report on the grounds disclosure would cause irreparable harm to the lawyer's reputation and career.

The unusual "reverse FOIA" case, is based on flimsy legal arguments that don't come close to meeting the narrow public-disclosure exceptions contained in the Food, Drug and Cosmetic Act, the agency asserts in a recently filed motion to dismiss.